Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Sales (2016 - 2025)

Historic Return on Sales for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to 0.06%.

  • Harvard Bioscience's Return on Sales rose 1600.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62%, marking a year-over-year decrease of 4700.0%. This contributed to the annual value of 0.13% for FY2024, which is 1000.0% down from last year.
  • As of Q3 2025, Harvard Bioscience's Return on Sales stood at 0.06%, which was up 1600.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Return on Sales ranged from a high of 0.08% in Q2 2022 and a low of 2.31% during Q1 2025
  • In the last 5 years, Harvard Bioscience's Return on Sales had a median value of 0.06% in 2025 and averaged 0.19%.
  • As far as peak fluctuations go, Harvard Bioscience's Return on Sales skyrocketed by 2600bps in 2023, and later tumbled by -21200bps in 2025.
  • Over the past 5 years, Harvard Bioscience's Return on Sales (Quarter) stood at 0.02% in 2021, then crashed by -526bps to 0.08% in 2022, then increased by 15bps to 0.06% in 2023, then soared by 103bps to 0.0% in 2024, then crashed by -3043bps to 0.06% in 2025.
  • Its Return on Sales was 0.06% in Q3 2025, compared to 0.11% in Q2 2025 and 2.31% in Q1 2025.